Tag

Yogesh M. Agrawal

1 article

Ajanta Pharma Q1 FY27 PAT Up 31% YoY

Ajanta Pharma's Q1 FY27 consolidated revenue grew 25% YoY to ₹1,626 cr, with PAT up 31% to ₹334 cr. Board declared a 1st interim dividend of ₹32 per share (face value ₹2), totaling a payout of ₹400 cr